Luo J.-M.NAI-KUAN CHOUNAI-HSIN CHIYIH-SHARNG CHENHSI-YU YUCHIH-HSIEN WANGKo W.-J.Tsao C.-I.Sun C.-D.SHOEI-SHEN WANG2021-05-072021-05-0720100041-1345https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955486307&doi=10.1016%2fj.transproceed.2010.02.047&partnerID=40&md5=2c74c1151368cc77d7201ec31af0faa0https://scholars.lib.ntu.edu.tw/handle/123456789/560328Cardiac transplantation is currently the only established surgical approach to the treatment of refractory heart failure. Heart transplantation because of amyloid cardiomyopathy continues to generate controversy because of donor shortage and concerns about disease recurrence in the allograft. We reviewed the medical records for all patients who underwent heart transplantation at our institution from 1987 to 2007, and found that 4 patients were diagnosed as having amyloid cardiomyopathy after pathologic examination of the excised hearts. No operative mortality was noted; however, all of the patients died of sepsis after transplantation. Because of the poor results, we do not recommended performing transplantation in patients with amyloidosis. Preoperative surveys and evaluation for amyloidosis must be emphasized in patients with hypertrophic cardiomyopathy. ? 2010 Elsevier Inc.[SDGs]SDG3allotransplantation; amyloidosis; article; case report; heart transplantation; human; male; middle aged; mortality; multiple myeloma; physiology; retrospective study; survival rate; time; Amyloidosis; Heart Transplantation; Humans; Male; Middle Aged; Multiple Myeloma; Retrospective Studies; Survival Rate; Time Factors; Transplantation, Homologousconference paper10.1016/j.transproceed.2010.02.047204302062-s2.0-77955486307